Friday, 4 September 2026
HiPerformance Culture GLOSSARY · Nutrition
Stylised hero illustration for the glossary entry on Homocysteine

Homocysteine n.

Normal range runs roughly 5 to 15 micromol per litre of blood; levels above 15 are classed as hyperhomocysteinaemia.

The definition

Homocysteine is a sulphur-containing amino acid generated during the methionine cycle as the body metabolises dietary protein. It is normally cleared by remethylation back to methionine, which depends on folate and vitamin B12, or by transsulfuration to cysteine, which depends on vitamin B6. Elevated levels, often linked to MTHFR gene variants or B-vitamin insufficiency, mark raised cardiovascular and cognitive risk.

53%

slower brain atrophy with B vitamins in MCI patients with the highest baseline homocysteine

SMITH ET AL. · 2010 4

The mechanism

Homocysteine arises in the methionine cycle whenever the body uses methionine from dietary protein for methylation reactions. Once methyl groups are donated, the resulting homocysteine is cleared through two competing routes: remethylation back to methionine, which requires folate and vitamin B12 as cofactors, or transsulfuration to cysteine, which requires vitamin B6 1. Which route dominates depends on cellular methylation demand and B-vitamin supply, so a shortfall in any one of the three vitamins can leave homocysteine circulating at higher concentrations than normal.

The MTHFR gene encodes the enzyme that generates the active form of folate needed for remethylation. Variants of this gene, particularly the C677T substitution, reduce enzyme activity and blunt homocysteine clearance, an effect that becomes most pronounced when dietary folate intake is also low 2. Carriers of the variant are not automatically at risk; the genetic predisposition and the nutritional shortfall compound each other.

The link between homocysteine and vascular disease traces back to McCully's original hyperhomocysteinaemia hypothesis, formed from observing arterial damage in children with the inherited disorder homocystinuria. McCully proposed that homocysteine itself injures the endothelium and arterial wall, a mechanism later extended to the far smaller elevations seen in the general population 3.

In practice

Clinicians increasingly use homocysteine testing to decide who is likely to benefit from B-vitamin supplementation, rather than prescribing the vitamins to everyone with a family history of heart disease.

Worked example

A person in their sixties with mild memory complaints has a blood test showing a homocysteine level of 18 micromol per litre, above the normal range. A clinician prescribes high-dose folate, B12 and B6 for two years. Follow-up scans show markedly slower brain shrinkage than expected, and repeat blood work confirms homocysteine has dropped back within the normal range.

The scenario only plays out this way because the starting homocysteine was elevated; the same regimen given to someone with a normal baseline level would not be expected to change much of anything.

Why it matters

Homocysteine is not simply a marker of risk; it identifies who is likely to respond when B vitamins are given. A two-year randomised trial in people with mild cognitive impairment and elevated homocysteine found that high-dose folate, B12 and B6 slowed whole-brain atrophy by 30% on average, and by 53% in the subgroup with the highest baseline homocysteine 4. Yet a pooled analysis of 11 trials covering roughly 22,000 people found that lowering homocysteine with B vitamins produced no significant benefit to global cognitive function overall, despite substantially reducing homocysteine concentrations 5.

The two findings are not contradictory once baseline homocysteine is treated as the deciding variable. Supplementation appears to help most reliably in people who already have elevated homocysteine or poor B-vitamin status, and to do little for those who are already adequately nourished 41.

Questions of record

What counts as a normal homocysteine level versus an elevated one?

A normal fasting homocysteine level generally falls between 5 and 15 micromol per litre of blood. Levels consistently above 15 micromol per litre are classed as hyperhomocysteinaemia, and this threshold is what most clinical studies use to define elevated risk rather than a single universal cutoff.

Does taking B vitamins actually lower homocysteine and improve your health?

B vitamins reliably lower your homocysteine level if it starts out high, but lowering the number does not automatically translate into better cognitive outcomes. A large pooled analysis of over 20,000 people found no overall cognitive benefit, while a trial focused on people with elevated homocysteine and mild impairment found a substantial one.

What causes high homocysteine, and does the MTHFR gene matter?

The most common cause is insufficient folate, vitamin B12 or B6, since your body needs all three to clear homocysteine efficiently. MTHFR gene variants, especially the C677T version, reduce the enzyme activity behind this clearance and raise your homocysteine most sharply when your folate intake is also low.

Is elevated homocysteine linked to heart disease risk?

The connection dates back to observations of arterial damage in children with a rare inherited disorder that causes very high homocysteine. That original hypothesis proposed homocysteine directly injures the artery wall, and it remains the basis for treating elevated levels as a cardiovascular risk marker, even though the much smaller elevations seen in most people are harder to study directly.

Sources

Sources
1 Smith & Refsum (2016) Homocysteine, B Vitamins, and Cognitive Impairment Annual Review of Nutrition DOI
2 Zarembska et al. (2023) The Implication of a Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Homocysteine Metabolism and Related Civilisation Diseases International Journal of Molecular Sciences DOI
3 McCully (2005) Hyperhomocysteinemia and arteriosclerosis: historical perspectives Clinical Chemistry and Laboratory Medicine (CCLM) DOI
4 Smith et al. (2010) Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial PLoS ONE DOI
5 Clarke et al. (2014) Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals The American Journal of Clinical Nutrition DOI

↑ Back to the headword